CEDAR KNOLLS, N.J.,
May 14, 2020 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a
bionutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
that helps build lean muscle, announced today that it has entered
into an agreement with Victor Medical
Company ("VMC") to distribute its
Veterinarian Strength MYOS Canine Muscle
Formula® ("MYOS Canine") nutrition products through
VMC's extensive distribution network across the Western United
States.
Founded over 40 years ago, VMC is the largest privately owned
veterinary distributor in California, Arizona, Nevada, and the Pacific Northwest. VMC
works with some of the largest global manufacturers of veterinary
supplies to offer a comprehensive portfolio of products to
veterinarians, including pharmaceuticals, surgical equipment, and
nutraceuticals.
Both MYOS Canine
products (Regular and
Veterinarian Strength) are based on MYOS' proprietary
ingredient, Fortetropin.
Fortetropin is manufactured from fertilized, chicken egg yolk using
a patented process that leverages advanced technologies that
maintain the bioactivity of the biomolecules found within
fertilized egg yolk.
To date, Fortetropin has been
studied in four human and veterinary clinical trials.
These clinical trials have demonstrated that Fortetropin
promotes the growth and development of muscle tissue and
accelerates muscle tissue recovery. In April 2020, clinical researchers at Kansas
State University College of Veterinary
Medicine published results from a randomized, double blind,
placebo-controlled clinical trial involving 100 dogs recovering
from TPLO surgery in the peer-reviewed journal, PLOS
ONE. TPLO surgery is performed to repair tears of the
cranial cruciate ligament (CCL) which is analogous to the anterior
cruciate ligament (ACL) in humans. During the period of
recovery following TPLO surgery, significant thigh muscle atrophy
normally occurs as the dog must keep its limb immobilized for 8
weeks. Dogs that received Fortetropin while recovering from
TPLO surgery experienced less muscle atrophy and improved recovery
in comparison to dogs that received a macronutrient-matched placebo
control.
"At Victor Medical, we take great pride in offering
first-class products to veterinarians that are backed by rigorous
scientific research. All of the products that we distribute undergo
an extensive, internal review process. We are truly impressed
by the extensive clinical research behind MYOS Canine Muscle
Formula.
"We are delighted to be working with Myos to make this product
available to our network of veterinarians on the west coast.
Victor Medical is an independent family regional distributor
which has been servicing the veterinary community since 1966,"
commented Rick Bills, Director of
Sales at Victor Medical.
"We are thrilled to be working with VMC and appreciate their
commitment to their customers. VMC's sales representatives have
come from the veterinary industry including veterinary technicians
who have worked in veterinary practices. We believe our
partnership with VMC will enable MYOS to greatly expand its
commercial footprint across the United
States," stated Joseph
Mannello, CEO of MYOS. "During these unprecedented
economic times, the fact that we are able to enter into an exciting
distribution partnership with a market leader speaks volumes to how
much demand there is for our innovative canine nutrition product,"
added Mr. Mannello.
About MYOS RENS Technology Inc.
MYOS RENS Technology
Inc. (MYOS), "The Muscle Company®", is a Cedar Knolls, NJ-based advanced nutrition
company that develops and markets products that improve muscle
health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin has been clinically shown to
increase muscle size, lean body mass and reduce muscle atrophy.
MYOS believes Fortetropin has the potential to redefine existing
standards of physical health and wellness and produces muscle
health support products featuring Fortetropin under the names of
MYOS Canine Muscle Formula®, (Regular &
Vet Strength) Yolked®, Physician Muscle
Health Formula®, and Qurr®.
For more information, please visit www.myosrens.com.
About Victor Medical
Victor Medical Company is the
largest privately-owned veterinary distributor in California, Arizona, Nevada, and Pacific Northwest. VMC is also a family company, founded
by people who believe in excellence and who are dedicated to
providing their customers with exceptional service. Guided by these
values, the company began over 40 years ago and continues to grow today. In
2002, VMC moved into a
state-of-the-art warehouse facility and implemented an automated,
order fulfillment system.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products,
including MYOS Canine Muscle
Formula®,
Yolked®, Physician Muscle Health
Formula®, Qurr®, and MYOS Enteral
Nutrition Formula™, the success of our research and
development, the results of the clinical evaluation
of Fortetropin® and its effects, the
ability to enter into new partnership opportunities and the success
of our existing partnerships, the ability to enter into new
distribution agreements such as the one described in this release,
the ability to generate revenue and cash flow from sales of our
products, the ability to increase our revenue and gross profit
margins, the ability to achieve a sustainable, profitable business,
the effect of economic conditions, the ability to protect our
intellectual property rights, competition from other providers and
products, the continued listing of our securities on
the Nasdaq Stock Market, risks in product development, our
ability to raise capital to fund continuing operations, the adverse
impact of the coronavirus pandemic on the economy and our business,
and other factors discussed from time to time in our filings
with the Securities and Exchange Commission. We undertake no
obligation to update or revise any forward-looking statement for
events or circumstances after the date on which such statement is
made except as required by law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor Relations:
MYOS RENS Technology
Joanne Goodford
Phone:973-509-0444
Email: jgoodford@myoscorp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-enters-into-agreement-with-victor-medical-to-distribute-myos-canine-muscle-formula-across-western-united-states-301059064.html
SOURCE MYOS RENS Technology